Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
reports
West Pharmaceutical Services (WST) Stock Price & Analysis
525 Followers
WST Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$205.87 - $422.87
Previous Close$268.62
Volume117.29K
Average Volume (3M)684.14K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$729.00M
Total Debt (Recent Filing)$299.90M
Price to Earnings (P/E)32.4
Beta1.36
Next EarningsFeb 16, 2023
EPS Estimate$1.38
Last Dividend Ex-DateJan 24, 2023
Dividend Yield0.74 (0.27%)
1Y Price Target$271.67
EPS (TTM)8.30
Shares Outstanding74,032,987
R-Squared0.46
Standard Deviation0.09
10 Day Avg. Volume625,687
30 Day Avg. Volume684,143
Price to Book (P/B)8.03
Price to Sales (P/S)8.82
Price to Cash Flow (P/CF)29.80
P/FCF Ratio71.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside2.59% Upside
Rating ConsensusModerate Buy
Alpha0.01
Number of Analyst Covering3
West Pharmaceutical Services News
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
WST FAQ
What was West Pharmaceutical Services’s price range in the past 12 months?
West Pharmaceutical Services lowest stock price was $205.87 and its highest was $422.87 in the past 12 months.
What is West Pharmaceutical Services’s market cap?
Currently, no data Available
When is West Pharmaceutical Services’s upcoming earnings report date?
West Pharmaceutical Services’s upcoming earnings report date is Feb 16, 2023 which is in 17 days.
How were West Pharmaceutical Services’s earnings last quarter?
West Pharmaceutical Services released its earnings results on Oct 27, 2022. The company reported $2.03 earnings per share for the quarter, missing the consensus estimate of $2.12 by -$0.09.
Is West Pharmaceutical Services overvalued?
According to Wall Street analysts West Pharmaceutical Services’s price is currently Undervalued.
Does West Pharmaceutical Services pay dividends?
West Pharmaceutical Services pays a Quarterly dividend of $0.19 which represents an annual dividend yield of 0.27%. See more information on West Pharmaceutical Services dividends here
What is West Pharmaceutical Services’s EPS estimate?
West Pharmaceutical Services’s EPS estimate is $1.38.
How many shares outstanding does West Pharmaceutical Services have?
West Pharmaceutical Services has 74,032,990 shares outstanding.
What happened to West Pharmaceutical Services’s price movement after its last earnings report?
West Pharmaceutical Services reported an EPS of $2.03 in its last earnings report, missing expectations of $2.12. Following the earnings report the stock price went down -13.039%.
Which hedge fund is a major shareholder of West Pharmaceutical Services?
Among the largest hedge funds holding West Pharmaceutical Services’s share is Fisher Asset Management LLC. It holds West Pharmaceutical Services’s shares valued at 40M.
---
West Pharmaceutical Services Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$271.67
$271.67
Blogger Sentiment
Bullish
WST Sentiment 60%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 310.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▲ 0.5%
Last 30 Days ▼ 2.3%
Last 30 Days ▼ 2.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.83%
12-Months-Change
Fundamentals
Return on Equity
26.99%
Trailing 12-Months
Asset Growth
5.54%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
---
---